Dr Reddys Drug Patent Portfolio
Dr Reddys owns 1 orange book drug protected by 2 US patents Given below is the list of Dr Reddys's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10993952 | Stable ready to use cyclophosphamide liquid formulations | 15 Feb, 2036 | Active |
| US12329767 | Stable Ready To Use Cyclophosphamide Liquid Formulations | 15 Feb, 2036 | Active |
Latest Legal Activities on Dr Reddys's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Dr Reddys.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 24 Jun, 2025 | US12329767 |
| Recordation of Patent eGrant | 17 Jun, 2025 | US12329767 |
| Mail Patent eGrant Notification | 17 Jun, 2025 | US12329767 |
| Email Notification | 17 Jun, 2025 | US12329767 |
| Patent eGrant Notification | 17 Jun, 2025 | US12329767 |
| Patent Issue Date Used in PTA Calculation | 17 Jun, 2025 | US12329767 |
| Email Notification | 05 Jun, 2025 | US12329767 |
| Issue Notification Mailed | 04 Jun, 2025 | US12329767 |
| Application Is Considered Ready for Issue | 16 May, 2025 | US12329767 |
| Dispatch to FDC | 16 May, 2025 | US12329767 |
| Issue Fee Payment Verified | 15 May, 2025 | US12329767 |
| Issue Fee Payment Received | 15 May, 2025 | US12329767 |
| Email Notification | 03 Apr, 2025 | US12329767 |
| Mail Notice of Allowance | 03 Apr, 2025 | US12329767 |
| Notice of Allowance Data Verification Completed | 01 Apr, 2025 | US12329767 |
Dr Reddys's Family Patents
Recent FDA approvals and tentative approvals for Dr Reddys
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Innovator drugs
Includes innovator drug submissions that appear in FDA approval and tentative approval disclosures.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Bendamustine Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 5 - New Formulation or New Manufacturer | 12 Nov, 2021 |
| Pemetrexed For Injection |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 5 - New Formulation or New Manufacturer | 14 May, 2020 |
| Zenavod |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | Type 5 - New Formulation or New Manufacturer | 27 Jan, 2016 |
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Lumateperone |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 06 Aug, 2025 |
| Carbidopa And Levodopa |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 13 Jun, 2025 |
| Siponimod |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 05 Jun, 2025 |
Dr Reddys Drug List
Given below is the complete list of Dr Reddys's drugs and the patents protecting them.
1. Cyclophosphamide
Cyclophosphamide is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10993952 | Stable ready to use cyclophosphamide liquid formulations |
15 Feb, 2036
(9 years from now)
| Active |
| US12329767 | Stable Ready To Use Cyclophosphamide Liquid Formulations |
15 Feb, 2036
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cyclophosphamide's drug page